medECUBE collaborates with Government agencies, signs MOUs in India and overseas

Gunjan Chauhan
Gunjan Chauhan
· 3 min read
OptraSCAN

medECUBE, NABH accredited Clinical Coordination Service provider has signed over 5 MoU’sand agreements with various international ministries and government bodies to work on setting up and operationalizing 100+super-speciality hospitals and improve healthcare delivery globally. With 12 international offices, medECUBE utilises its strong network strength to identify and initiate partnerships which benefit medical community and enhance clinical expertise at a local level. In just over a year, medECUBE has facilitated 12 surgical camps, 100+ doctor trainings and clinical observer-ships and coordinated clinical care for over10,000 domestic and international patients.

MOU / Agreement Key objective
South Sudan Investment Authority (SSIA)

 

Operationalization of an Oncology hospital & centralization of 5 exsisting hospitals including efficiency creation
Ministry of Health of the Government of the Republic Zambia To construct, operationalize and manage 3 multispecialty hospitals
West Kazakhstan Marat Ospanov State Medical University

 

Cooperate in the areas of modernization of medical education; Cooperate in development of innovative education technologies, including distance learning;  Develop a management system and the financing of medical education; Increase capacity of teaching staff and employees and more
Tata Trusts – Ala Melu Charitable Trust

 

To develop and operationalize over one hundred cancer centres – help create process and protocols, equipment and manpower planning

The first such MOU was signed a year ago in June, 2017. Since then, medECUBE has established a framework for collaboration within India, and between India and various other countries such as Zambia, Sudan, Kazhakstan, etc. Within India, medECUBE collaborates with Tata Trusts – Ala Melu Charitable Trust to develop and operationalize over one hundred cancer centres. Overseas, medECUBE collaborates with ministries and organisations likes South Sudan Investment Authority (SSIA), West Kazakhstan Marat Ospanov State Medical University at Kazakhstan and the Ministry of Health of the Government of Zambia.

Dr. Dilpreet Brar, Founder and MD, medECUBE said ‘’Health systems are expected to serve the population needs in an effective, efficient and equitable manner. Therefore, the importance of strengthening of public, private and community health systems has been emphasized time and again. We at medECUBE take pride in opening new avenues of cooperation with these associations and celebrate it as an addition to the company’s achievements. We are really keen to diversify these partnerships and take advantage of the successes and learnings from each other’s experiences. In most of the developing countries, certain limitations of the government health systems have been hindering the achievement of improved health outcomes, this is where we need to step-in and create an impact on the sector’’. 

MedECUBE has agreements with over 150 Hospitals across the world – in India, Thailand, Singapore, USA, UK, Turkey, Easter Europe, Central Asia, Middle -East and Africa. We have over 100 Key Opinion Leader (KOL) clinicians on our global panel of second opinion providers. For people specifically looking for alternatives to Western medicine, we have 10 wellness retreats and alternate medicine facilities. These partners ensure clinical excellence and medECUBE ensures clinical coordination.

The objective of these collaborations is to establish comprehensive inter-ministerial and inter-institutional cooperation between the countries in the field of health by pooling technical, scientific, financial and human resources with the ultimate goal of upgrading clinical care, medical education, training, and research.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk